Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease - Wikidata - wikimedia - TriplyDB

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

http://www.wikidata.org/entity/Q36932748

about

Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Ageing, neurodegeneration and brain rejuvenation APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective Neuroinflammation in Alzheimer's disease Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid.Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort.Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential.Gata5 deficiency causes airway constrictor hyperresponsiveness in mice.The future of blood-based biomarkers for Alzheimer's disease.Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype Developing novel blood-based biomarkers for Alzheimer's disease Plasma based markers of [11C] PiB-PET brain amyloid burden.Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson's Disease.SMA-MAP: a plasma protein panel for spinal muscular atrophy Progress in Alzheimer's disease research in the last year.Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel.Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort.Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease.Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer's disease Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease Plasma BDNF levels associate with Pittsburgh compound B binding in the brain Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification.Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele.Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men.Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study.HDL-cholesterol and apolipoproteins in relation to dementia.Rationalising the role of Keratin 9 as a biomarker for Alzheimer's disease.The link between C-reactive protein and Alzheimer's disease among Mexican Americans.

P2860

Q26774743-1EF24636-3BD1-453B-A5C4-F79A2F9A4258 Q27006831-5347ADD2-B7AE-4F26-B6D5-D3441AAC65AD Q28071590-2719015E-ABFA-4E01-B778-2CD2DC506E34 Q28085213-038EE68D-DC22-4960-8983-39A01E1C8DD9 Q28259238-559D519A-E274-4832-93C5-35556E9E18D8 Q28542010-563A8FDA-6FD1-4B04-89F4-B9FA1F7EE4D0 Q28547333-DAB1961E-652D-4DA2-8731-EF710BC34AD2 Q30971403-D7F2EC6C-435B-4090-8BFE-8D61975EB03C Q31110973-0E15EF99-F39D-485A-BB0E-3813B303117D Q33554802-C1785B3A-1C92-42C3-A67B-9B5E1BD403E2 Q33652456-3277EC5F-2FE0-4FEC-BB63-B0B5E2551B8C Q33692408-89C74BC6-EB17-4597-96E3-A912825CABAE Q33799596-0DCC063F-5731-4B74-9297-D3BD5AB22150 Q34026317-F8783C0C-66C9-492E-8687-C072C65E9575 Q34277859-1BACA689-2D19-4E45-A744-5BF4B084C954 Q34363475-3627AA59-EBF1-4D6C-9102-940035C11EEF Q34394080-38D757B7-01E0-431F-B389-857336D444CD Q34427001-67A7BEB0-81DD-432C-8E65-F2FC71425FE4 Q34438204-B5B24693-512F-455A-9C4D-B6D823E969B9 Q34658131-8C5337AC-0A50-484E-8AB7-6D5A91F11A99 Q34675868-CA8AE3A4-1CE4-4541-BFE3-DD0C4399D2B0 Q34769550-66D93847-E1A0-4694-9F29-B08F6C17796A Q34875967-48192096-EDE9-41AB-9AC4-A322EA88E2F8 Q35034827-181C80E7-8632-47A0-9628-F0108D153A0C Q35071184-4C77A6BB-BEE4-4FB7-AFC6-36798B2B129A Q35099780-21C245C2-F92A-401F-B5A0-F46DF8DAA071 Q35106592-71ECF9DE-F990-4261-B483-26362036462A Q35158376-8505F273-6166-4CC9-9602-0CC9017D8B08 Q35502548-744ED56E-E4A0-4CD4-930B-B20821D29BC5 Q35812498-4A8438C1-5BC1-4DA4-B0CA-C2996BED6362 Q35843380-CEBDE530-2D34-4B6A-BD50-FDAB4D164CF5 Q35865843-AE375AA5-6B09-4DDC-BBA1-1255398362BC Q35930947-B868C9A6-2B51-4B8A-983A-1CD844A7E8FB Q36033650-DF1CB868-D853-429B-B7F0-43FFAD9B3F58 Q36256076-4A56865D-2787-4849-8C67-26DDB8B0375D Q36349870-177D9B2C-1443-42C5-B31A-A84849275C3E Q36353787-C536351A-5C4E-41DA-9909-BD3D9F239E16 Q36436743-FCE90697-D503-4779-A4B9-44BE285237CF Q36681693-C16C15E6-0E48-4369-AF83-3AC3237B4D9A Q36716958-D5EFA0A1-9BE7-4A37-B3B5-A45590BAD908

P2860

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

http://www.wikidata.org/entity/Q36932748

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

@en

type

label

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

@en

prefLabel

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

@en

P1433

Q36932748-024B1D7E-8E48-4434-88AF-073BBE01EC54

P1476

Q36932748-8E4C45E3-E1CD-49ED-951E-FB8CE1F6A3A1

P2093

Q36932748-05F97A5F-0B38-4091-8F06-83185576B9FC

Q36932748-0749D81F-2641-4F56-9425-440C27F4358A

Q36932748-14ACB20D-5F70-4CFF-B0E8-FF5DC9E7EA9F

Q36932748-37BE552B-49F4-4362-9F79-0B751B219A70

Q36932748-494E4753-C962-4949-9EA1-A7961DD430A3

Q36932748-4BF04840-8B4F-411A-8685-1616DFFE100A

Q36932748-4EC9187D-20F8-4456-BD64-5F48EEE3546C

Q36932748-6741379E-F651-41EB-AB63-BAD2EC0A2147

Q36932748-6B5355FC-26C3-4647-A919-95A72705057C

Q36932748-6EA8DA53-9867-454E-A860-E5D051A0DDB0

P2860

Q36932748-05A7C5D6-330F-4048-963E-88A91FF297FD

Q36932748-07E7A92C-4658-4A35-80DA-DA324BC9F335

Q36932748-0A335724-0AE7-4700-A57B-4BFC1249C046

Q36932748-225CF12E-2F67-4DF3-87E3-BD054A6F0E02

Q36932748-22A4DB7B-B07F-4334-B673-292B65B04E3D

Q36932748-2EC51749-B06E-4FA7-9E84-A4FF799CDEEA

Q36932748-2FCDD355-C095-4A5F-938A-625E543941E9

Q36932748-364F391B-E8AE-4A0E-B5BD-754B73377AAA

Q36932748-36D57671-B0F2-408F-B8F5-F1B493E74EC2

Q36932748-3E8BDFD7-F231-41BA-B5A7-7E9E26D3AFB8

P304

Q36932748-F060CF32-BEB5-4795-A11B-D2237455E590

P31

Q36932748-02B3EA33-7DBA-4951-AB4B-5D078FB8DFD2

P356

Q36932748-5162427D-9709-46DD-863E-80D753BDC87F

P433

Q36932748-F1F3B097-6047-4579-B24E-3C3FC5A3BDD1

P478

Q36932748-A0867DAC-8456-41D5-AD79-07DB27114310

P50

Q36932748-464B780D-C5F0-4A93-B50C-3D98D04D12B5

Q36932748-84095002-DD41-45C7-B02F-BC8375889E69

P577

Q36932748-02FD8041-D2B7-4A78-BA2C-7CA1A1CD0BEE

P698

Q36932748-9597336D-38B3-40A8-9D4C-56DE25B8B25A

P921

Q36932748-2776B5C8-00ED-4C33-A726-872277790A9B

Q36932748-2F3CDC37-24C7-4131-9158-4446586F8030

P932

Q36932748-66E8D278-C184-4AE4-B00A-FD0B09EC0C34

P356

ARCHNEUROL.2012.1070

P1433

P1476

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

@en

P2093

Adam J Simon

http://www.w3.org/2001/XMLSchema#string

Biomarkers Consortium Alzheimer's Disease Plasma Proteomics Project

http://www.w3.org/2001/XMLSchema#string

David M Shera

http://www.w3.org/2001/XMLSchema#string

Eve Pickering

http://www.w3.org/2001/XMLSchema#string

Frank Swenson

http://www.w3.org/2001/XMLSchema#string

Frederick W Immermann

http://www.w3.org/2001/XMLSchema#string

Holly D Soares

http://www.w3.org/2001/XMLSchema#string

Hong I Wan

http://www.w3.org/2001/XMLSchema#string

Judith A Siuciak

http://www.w3.org/2001/XMLSchema#string

June Kaplow

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Mild cognitive impairment: an overview.

Mining biomarkers in human sera using proteomic tools.

B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia.

P304

1310-1317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2012.1070

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

John Q. Trojanowski

Madhav Thambisetty

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22801723

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3683865

http://www.w3.org/2001/XMLSchema#string